[1] Allan G M, Ellis J A. Porcine circoviruses: a review. Journal of Veterinary Diagnostic Investigation, 2000 (12):3-14.
[2] Allen G M, McNeilly F, Cassidy J P, Reilly G A C, Adair B, Ellis W A, McNulty M S. Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material. Veterinary Microbiology, 1995 (44):49-64.
[3] Chae C A. review of porcine circovirus 2-associated syndromes and diseases. Veterinary Journal, 2005 (169):326-336.
[4] Meehan B M, McNcilly F, Todd D, Kennedy S, Jewhurst V A, Ellis J A, Hassard L E, Clark E G, Haines D M, Allan G M. Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. Journal of General Virology, 1998, (79): 2171-2179.
[5] Silva F M, Silva Júnior A, Vidigal P M, Oliveira C R, Viana V W, Silva C H, Vargas M I, Fietto J L, Almeida M R. Porcine circovirus-2 viral load versus lesions in pigs: perspectives for post-weaning multisystemic wasting syndrome. Journal of Comparative Pathology, 2011, 144(4):296-302.
[6] Guo L J, Lu Y H, Wei Y W, Huang L P, Liu C M. Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China. Veterinary Journal, 2010, 19,(7):273.
[7] Crowther R A, Berriman J A, Curran W L, Allan G M, Todd D. Comparison of the structures of three circoviruses: chicken anemia virus, porcine circovirus type 2, and beak and feather disease virus. Journal of Virology, 2003(77):13036-13041.
[8] Porntippa Nawagitgul, Igor Morozov, Bolin S R, Harms P A, Sorden S D, Paul P S. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. Journal of General Virology, 2000, 81:2281-2287.
[9] Blanchard P, Mahe D, Cariolet R, Keranflech A, Baudouard M A, Cordioli P, Albina E, Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine, 2003(21): 4565-4575.
[10] Ellis J, Clark E, Haines D, West K, Krakowka S, Kennedy S. Virus-like particles: The new frontier of vaccines for animal viral infections. Veterinary Immunology and Immunopathology, 2012 (148): 211-225.
[11] Khayat R, Brunn N, Speir, J A Hardham J M, Ankenbauer R G, Schneemann A, Johnson J E. The 2.3-angstrom structure of porcine circovirus 2. Journal of Virology, 2011(8): 7856-7862.
[12] Nawagitgul P, Harms P A, Morozov I, Thacker B J, Sorden S D, Lekcharoensuk C, Paul P S. Modified indirect porcine circovirus (PCV) type 2-based and recimbinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clinical and Diagnostic Laboratory Immunology, 2002(9): 33-40.
[13] Sergio A B, Jorge N, Paulina R, Cecilia T, Leonardo S, Alejandro Z, Jaime A T. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine, 2009, (27): 5781-5790.
[14] Zhou J Y, Shang S B, Gong H, Chen Q X, Wu J X, Shen H G, Chen T F, Guo J Q. In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. Journal of Biotechnology, 2005(118):201-211.
[15] Wu P C, Lin W L, Wu C M, Chi J N, Chien M S, Huang C J. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Applied Microbiology and Biotechnology, 2012(95): 1501-1507.
[16] Yin S H, Sun S Q, Yang S L, Shang Y J, Cai X P, Liu X T. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli. Veterinary Journal, 2010(7): 166-170.
[17] Kong W T, Kong J, Hu S M, Lu W W, Wang K, Ji M J. Enhanced expression of PCV2 capsid protein in Escherichia coli and Lactococcus lactis by codon optimization. World Journal of Microbiology Biotechnology, 2011(27):651-657.
[18] Liu Q, Willson P, Attoh-Poku S, Babiuk L A. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Expression and Purification, 2001, 21(1): 115-120.
[19] Tischer I, Gelderblom, H, Vettermann, W, Koch M A. A very small porcine virus with circular single-stranded DNA. Nature, 1982, 295(5844): 64-66.
[20] Darwich L, Mateu E. Immunology of porcine circovirus type 2 (PCV2). Virus Research, 2012(164): 61- 67.
[21] Lekcharoensuk P, Morozov I, Paul P S, Thangthumniyom N, Wajjawalku W, Meng X J. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. Journal of Virology, 2004, 78(15): 8135-8145.
[22] Beach N M, Meng X J. Efficacy and future prospects of commercially available and experimental vaccinea agast porcine circovirus type 2. Virus Research, 2012,164: 33-42.
[23] Yang X, Chen F W, Cao Y H, Pang D X, Ouyang H S, Ren L Z. Comparative analysis of different methods to enhance porcine circovirus 2 replication. Journal of Virological Methods, 2013(187): 368-371.
[24] Tischer I, Peters D, Rasch R, Pociuli S. Replication of porcine circovirus: induction by glucosamine and cell cycle dependence. Archives of Virology, 1987, 96(1/2) 39-57.
[25] Gabriel Chena H C, Kuob T Y, Yangb Y C, Wuc C C, Lai S S. Highly permissive subclone of the porcine kidney cell line for porcine circovirus type 2 production. Journal of Virological Methods, 2013(187): 380-383.
[26] Fenaux M, Halbur P G, Haqshenas G, Royer R, Thomas P, Nawagitgul P, Gill M, Toth T E, Meng X J. Cloned genomic DNA of type2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease virus distribution, and pathologic lesions. Journal of Virology, 2002, 76(2): 541-551.
[27] Ludwig C, Wagner R. Virus-like particles-universal molecular toolboxes. Current Opinion in Biotechnology, 2007(18):537-545.
[28] Grgacic E V L, Anderson D A. Virus-like particles: Passport to immune recognition. Methods, 2006(40): 60-65.
[29] Kumann J, Sydler T, Brugnera E, Buergi E, Haessig M, Suter M, Sidler X. Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinical lyinfected with porcine circorus type 2. Clinical Vaccine Immunology, 2011, 18(10): 1644-1649.
[30]Trible B R, Ramirez A, Suddith A, Fuller A, Kerrigan M, Hesse R, Nietfeld J, Guo B Q, Thacker E, Rowland R R R. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition. Vaccine, 2012(30): 4079- 4085. |